The studies showing meaningful weight loss with GLP-1 medications arent about raising GLP-1 levelstheyre about activating GLP-1 receptors at a different level than your body produces naturally
Even with decreased unit prices these medications will continue to cause financial challenges for many employer sponsored health plans
Dose-response improvements in glycaemic control and body weight reduction with HM11260C, a once weekly GLP-1 receptor agonist with liraglutide as reference, in type 2 diabetes.[abstract]
We dont know what these molecules do to a fetus or growing infant. Clinicians must carefully counsel patients For women who desire pregnancy, the conversation about if or when to initiate a GLP-1 should begin as early as possible, Boots said
The study will span 1-2 months, providing important insights into the products benefits for metabolic health and overall well-being.
When taking the drug for diabetes, realize that elevated blood sugar is more dangerous in the long term, so a risk-benefit analysis needs to be undertaken, especially if one is unable to control their blood sugar through dietary means